About Lauren Foster

Lauren joined JensonR+ in 2023 after completing her degree in Medical Physiology and Therapeutics in 2021. Lauren has experience as a Clinical Research Technician, actively contributing to the execution of Phase I trials and within the Regulatory team at JensonR+, she supports a range of clients over various regulatory tasks.

MHRA First IRP Approval

2024-03-05T14:42:41+00:00March 6th, 2024|

The MHRA has announced the first authorisation via the International Recognition Procedure (IRP). The approval, granted within a 30-day timeframe, marks a milestone in accelerating the availability of essential medications for UK patients.

EMC webinar

2024-02-20T16:13:48+00:00February 21st, 2024|

In a recent webinar, members of the Datapharm team delved into the accessibility of the Electronic Medicines Compendium (EMC) for healthcare professionals (HCPs) and patients/carers. The discussion brought to light compelling statistics that shed light on user behaviour and preferences when accessing medical information online.

ASA x Instagram

2023-12-19T13:32:21+00:00December 20th, 2023|

In a recent campaign, the Advertising Standards Authority (ASA) joined forces with Instagram and five content creators to increase awareness of the ASA system. Are you familiar with the code of practice?

COSMILE Europe Database

2023-12-11T12:31:23+00:00December 12th, 2023|

The list of ingredients on the back of your favourite lotion or shampoo can often resemble a series of cryptic codes. The launch of the COSMILE Europe app provides accessible information on cosmetic ingredients, allowing consumers to be better informed about the products they are using.

MHRA Regulatory Procedures

2023-11-17T09:47:45+00:00November 16th, 2023|

There are notable advancements in the MHRA’s efforts to address their backlog and enhance overall efficiency in application processes across the board and there are some key areas where developments can be seen progressing rapidly.

MHRA’s New Streamlined Notification Scheme

2024-01-18T15:34:33+00:00November 8th, 2023|

In a significant stride towards enhancing the efficiency of clinical trials, the MHRA has introduced a streamlined notification scheme. This initiative, which was endorsed by a resounding 74% of respondents to the MHRA’s clinical trials consultation, forms a key part of the overhaul to the clinical trials regulation in the UK.


2023-11-06T11:33:06+00:00November 6th, 2023|

November 6th marks the start of the eighth annual MedSafetyWeek. This year’s campaign led by the Medicines and Healthcare products Regulatory Agency (MHRA), is all about the power of reporting.

Go to Top